Clinical Practice Guidelines- Management Of Acute ST Segment Elevation Myocardial Infarction (STEMI) 2014 - (3rd edition)

MESSAGE FROM THE DIRECTOR GENERAL OF HEALTH

ST segment myocardial infarction (STEMI) is the most deadly among the clinical presentations of acute coronary syndrome (ACS). Unlike many medical conditions, STEMI is associated with high mortality and morbidity in its early stages, including sudden death. The National Cardiovascular Disease (NCVD) ACS Registry revealed that there was a 10% mortality for patients who were admitted to hospital with STEMI in 2006-2008.

Since the publication of the 2nd Edition of the Malaysian Clinical Practice Guidelines (CPG) for the management of STEMI in 2007, there have been advances in the way STEMI is managed by the medical community, and more specialised centres providing leading-edge care for this condition. Therefore, it is timely for the publication of this 3rd edition of the Malaysian
CPG for STEMI.

It is testament to the commitment of the team of experts involved who are continuing to pursue the update of this and other CPGs. The pace of innovation in medicine has relentless in recent years, especially so in the area of cardiovascular medicine, in terms of both medical and interventional management.

There is a continual effort to not only update the CPGs but also improve the process of selecting and evaluating evidence. In addition, the incorporation of local data will make Malaysian CPGs more relevant document in the local context. I envisage many young physicians, generalists and allied health professionals will use these CPGs as a useful reference.

I acknowledge that this is not an insignificant effort given other clinical and leadership responsibilities of all those directly involved, and thank the team of authors and reviewers for their time and valuable contributions. I believe this CPG will be an invaluable document for healthcare providers involved in the management of STEMI and subsequently to improve health outcomes associated with this deadly condition.

 

Datuk Dr. Noor Hisham bin Abdullah

The Director General of Health, Ministry of Health Malaysia

 

This document is an update and supersedes the previous CPG on STEMI (2007)

 

Download the full document below: